Natera Company

Natera is a global leader in providing cell-free DNA testing across multiple clinical areas including women's health, organ health, and oncology. Natera offers a full menu of high-quality genetic tests to support the entire spectrum of women’s health needs—from planning a family and prenatal testing to hereditary cancer screening.
Technology: Pregnancy biomarkers, Biomarkers of Female Cancers
Industry: Longevity
Headquarters: San Carlos, California, United States
Founded Date: 01-01-2004
Employees Number: 1001-5000
Funding Status: IPO
Investors Number: 15
Total Funding: $409,100,000
Estimated Revenue: $50M to $100M
Last Funding Date: 2022-03-16
Last Funding Type: Post-IPO Equity

Visit Website
info@natera.com
http://twitter.com/NateraPrenatal
Register and Claim Ownership